Senior Director, Clinical Supply Release & QA Excellence

Madrigal Pharmaceuticals; Conshohocken (Montgomery County); On-site; USD 245,000 - 299,000; Full time

Benefits offered by this job

Equity opportunities

Job summary

At Madrigal Pharmaceuticals, we seek an experienced QA professional to own disposition and release of clinical supplies, ensuring compliant, audit-ready workflows and documentation. You will collaborate with Clinical Ops, CMC, Supply Chain, and vendors to prevent release bottlenecks and maintain inspection readiness.

The role requires 15+ years of GMP QA/release experience, strong documentation discipline, and travel up to 30% domestically and internationally.

Qualifications

• BS in science or engineering or related field.
• 15+ years GMP QA / release experience (clinical supply strongly relevant).
• Strong documentation discipline and cross-functional coordination.
• Willingness to travel 20–30% domestically and internationally.

Responsibilities

• Own release criteria, checklists, and documentation standards, ensuring consistent, compliant disposition decisions.
• Drive cycle-time and right-first-time improvements for clinical release workflows.
• Produce deliverables such as release checklists, dashboards, and clinical release cycle-time reports.
• Ensure QA oversight over clinical packaging runs and vendor oversight (as applicable).
• Coordinate deviations / investigations / change controls impacting release timelines, with risk-based assessments.

Skills

Documentation discipline

Cross-functional coordination

Travel readiness

Education

BS in Science / Engineering

Job description

At Madrigal Pharmaceuticals, we seek an experienced QA professional to own disposition and release of clinical supplies, ensuring compliant, audit-ready workflows and documentation. You will collaborate with Clinical Ops, CMC, Supply Chain, and vendors to prevent release bottlenecks and maintain inspection readiness.

The role requires 15+ years of GMP QA/release experience, strong documentation discipline, and travel up to 30% domestically and internationally.